 | • レポートコード：GIR-2104Z06334 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、胃腸治療・診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。胃腸治療・診断の種類別市場規模（診断、治療）、用途別市場規模（胃腸炎、消化管出血、過敏性腸症候群、消化性潰瘍疾患（PUD）、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・胃腸治療・診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、AstraZeneca、Eisai、Johnson & Johnson、Salix Pharmaceuticals、Takeda Pharmaceutical Company ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：診断、治療 ・用途別分析2016年-2026年：胃腸炎、消化管出血、過敏性腸症候群、消化性潰瘍疾患（PUD）、その他 ・胃腸治療・診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・胃腸治療・診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・胃腸治療・診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・胃腸治療・診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・胃腸治療・診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gastrointestinal Therapeutics and Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gastrointestinal Therapeutics and Diagnostics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Gastrointestinal Therapeutics and Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gastrointestinal Therapeutics and Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diagnostics
Therapeutics
Market segment by Application, can be divided into
Gastroenteritis
GI Bleeding
Irritable Bowel Syndrome
Peptic Ulcer Disease (PUD)
Others
Market segment by players, this report covers
Abbott Laboratories
AstraZeneca
Eisai
Johnson & Johnson
Salix Pharmaceuticals
Takeda Pharmaceutical Company
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Gastrointestinal Therapeutics and Diagnostics
1.2 Classification of Gastrointestinal Therapeutics and Diagnostics by Type
1.2.1 Overview: Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type in 2020
1.2.3 Diagnostics
1.2.4 Therapeutics
1.3 Global Gastrointestinal Therapeutics and Diagnostics Market by Application
1.3.1 Overview: Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Gastroenteritis
1.3.3 GI Bleeding
1.3.4 Irritable Bowel Syndrome
1.3.5 Peptic Ulcer Disease (PUD)
1.3.6 Others
1.4 Global Gastrointestinal Therapeutics and Diagnostics Market Size & Forecast
1.5 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast by Region
1.5.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Gastrointestinal Therapeutics and Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastrointestinal Therapeutics and Diagnostics Market Drivers
1.6.2 Gastrointestinal Therapeutics and Diagnostics Market Restraints
1.6.3 Gastrointestinal Therapeutics and Diagnostics Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product and Solutions
2.1.4 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product and Solutions
2.2.4 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 Eisai
2.3.1 Eisai Details
2.3.2 Eisai Major Business
2.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Product and Solutions
2.3.4 Eisai Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eisai Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product and Solutions
2.4.4 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Salix Pharmaceuticals
2.5.1 Salix Pharmaceuticals Details
2.5.2 Salix Pharmaceuticals Major Business
2.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product and Solutions
2.5.4 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Salix Pharmaceuticals Recent Developments and Future Plans
2.6 Takeda Pharmaceutical Company
2.6.1 Takeda Pharmaceutical Company Details
2.6.2 Takeda Pharmaceutical Company Major Business
2.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product and Solutions
2.6.4 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Takeda Pharmaceutical Company Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gastrointestinal Therapeutics and Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Gastrointestinal Therapeutics and Diagnostics Players Market Share
3.2.2 Top 10 Gastrointestinal Therapeutics and Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Gastrointestinal Therapeutics and Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gastrointestinal Therapeutics and Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Gastrointestinal Therapeutics and Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Gastrointestinal Therapeutics and Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2016-2026)
6.2 North America Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2016-2026)
6.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country
6.3.1 North America Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2016-2026)
7.2 Europe Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2016-2026)
7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country
7.3.1 Europe Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region
8.3.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue by Region (2016-2026)
8.3.2 China Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2016-2026)
9.2 South America Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2016-2026)
9.3 South America Gastrointestinal Therapeutics and Diagnostics Market Size by Country
9.3.1 South America Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country
10.3.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Gastrointestinal Therapeutics and Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Gastrointestinal Therapeutics and Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 9. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca Major Business
Table 12. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 13. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Eisai Corporate Information, Head Office, and Major Competitors
Table 15. Eisai Major Business
Table 16. Eisai Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 17. Eisai Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 21. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Salix Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Salix Pharmaceuticals Major Business
Table 24. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 25. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Takeda Pharmaceutical Company Corporate Information, Head Office, and Major Competitors
Table 27. Takeda Pharmaceutical Company Major Business
Table 28. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product and Solutions
Table 29. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 31. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Players (2019-2021)
Table 32. Breakdown of Gastrointestinal Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Gastrointestinal Therapeutics and Diagnostics Players Head Office, Products and Services Provided
Table 34. Gastrointestinal Therapeutics and Diagnostics Mergers & Acquisitions in the Past Five Years
Table 35. Gastrointestinal Therapeutics and Diagnostics New Entrants and Expansion Plans
Table 36. Global Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 37. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Type (2016-2021)
Table 38. Global Gastrointestinal Therapeutics and Diagnostics Revenue Forecast by Type (2021-2026)
Table 39. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2016-2021)
Table 40. Global Gastrointestinal Therapeutics and Diagnostics Revenue Forecast by Application (2021-2026)
Table 41. North America Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Gastrointestinal Therapeutics and Diagnostics Picture
Figure 2. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type in 2020
Figure 3. Diagnostics
Figure 4. Therapeutics
Figure 5. Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application in 2020
Figure 6. Gastroenteritis Picture
Figure 7. GI Bleeding Picture
Figure 8. Irritable Bowel Syndrome Picture
Figure 9. Peptic Ulcer Disease (PUD) Picture
Figure 10. Others Picture
Figure 11. Global Gastrointestinal Therapeutics and Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Gastrointestinal Therapeutics and Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Region (2016-2026)
Figure 14. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Region in 2020
Figure 15. North America Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Gastrointestinal Therapeutics and Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Gastrointestinal Therapeutics and Diagnostics Market Drivers
Figure 20. Gastrointestinal Therapeutics and Diagnostics Market Restraints
Figure 21. Gastrointestinal Therapeutics and Diagnostics Market Trends
Figure 22. Abbott Laboratories Recent Developments and Future Plans
Figure 23. AstraZeneca Recent Developments and Future Plans
Figure 24. Eisai Recent Developments and Future Plans
Figure 25. Johnson & Johnson Recent Developments and Future Plans
Figure 26. Salix Pharmaceuticals Recent Developments and Future Plans
Figure 27. Takeda Pharmaceutical Company Recent Developments and Future Plans
Figure 29. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Players in 2020
Figure 30. Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Gastrointestinal Therapeutics and Diagnostics Revenue Market Share in 2020
Figure 32. Global Top 10 Players Gastrointestinal Therapeutics and Diagnostics Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Type in 2020
Figure 35. Global Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Type (2021-2026)
Figure 36. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Application in 2020
Figure 37. Global Gastrointestinal Therapeutics and Diagnostics Market Share Forecast by Application (2021-2026)
Figure 38. North America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Type (2016-2026)
Figure 39. North America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Application (2016-2026)
Figure 40. North America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Country (2016-2026)
Figure 41. United States Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Type (2016-2026)
Figure 45. Europe Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Application (2016-2026)
Figure 46. Europe Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Country (2016-2026)
Figure 47. Germany Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Region (2016-2026)
Figure 55. China Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Type (2016-2026)
Figure 62. South America Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Application (2016-2026)
Figure 63. South America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Gastrointestinal Therapeutics and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
世界のペプチドベース胃腸障害治療薬市場規模・現状・予測（2021年-2027年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…- 世界の胃腸用治療市場規模・現状・予測（2021年-2027年） Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarr…
- 世界の胃腸障害治療市場規模・現状・予測（2021年-2027年） Gastrointestinal disorder is mainly associated with the impairment of gastrointestinal functions that are affected mainly by contaminated or poisonous food. Gastrointestinal disorders includes irritable bowel syndrome, gastroesophageal reflux diseases and peptic ulcer diseases. Increasing incidences…
- 世界の脳卒中診断＆治療市場規模・現状・予測（2021年-2027年） Stroke refers to the brain attack. Stroke occurs when the supply of blood to the brain is either interrupted or reduced. Increasing number of mergers and acquisitions, rapid product launches, and rise in number of collaborations and partnerships are some of the latest trends that have been observed …
- 世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年） Alzheimers is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. Alzheimers is one of the leading causes of death in the United States, with more than 5 million Americans diagnosed with this dreaded disease, in year 2014. Market Analysis and Insights: Glob…